Back to Authors

Weiss, Sharon Whelan

0000-0002-0981-6917

A5003047676 | I150468666

Mayo Clinic

Emory University

Citations 4

In Reply

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 131 | Issue: 5 | Pages: 681-682

10.5858/2007-131-681-ir

Protocol for the Examination of Specimens From Patients With Soft Tissue Tumors of Intermediate Malignant Potential, Malignant Soft Tissue Tumors, and Benign/Locally Aggressive and Malignant Bone Tumors

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 130 | Issue: 11 | Pages: 1616-1629

10.5858/2006-130-1616-pfteos | PMID 17076523

Lymphatic-type “Angiosarcoma” With Prominent Lymphocytic Infiltrate

American Journal of Surgical Pathology | November 4, 2019 | Volume: 44 | Issue: 2 | Pages: 271-279

10.1097/pas.0000000000001398 | PMID 31688141

We report 21 cases of a distinctive and unique vascular tumor which we propose to be a pure lymphatic-type angiosarcoma characterized by architectural and growth characteristics of angiosarcoma, cytologic, and immunohistochemical features of lymphatic differentiation, a prominent lymphocytic infiltrate, and variable nuclear grade. Patients included 12 males and 9 females with a median age of 65 years (range: 32 to 95 y). Tumors involved the head and neck (n=11), lower extremities (n=5), trunk (n=4), and upper extremity (n=1) and were located superficially in the dermis and/or subcutis. Tumors were designated “low grade” (n=10) when the nuclear grade was low, and vascular channel formation was evident throughout but with multilayering of endothelium within the vessels. Cases were designated “high grade” (n=11) when nuclei appeared higher grade with more rounded contours and prominent nucleoli and when solid areas predominated over vascular channel formation. A striking feature of both groups was the presence of a dense, lymphocytic infiltrate with occasional germinal center formation. All cases strongly and diffusely expressed at least 1 lymphatic marker (21/21) with podoplanin (17/19) and Prox-1 (11/11) more commonly expressed than LYVE-1 (5/10). No consistent molecular alteration was identified. Follow-up on 17 patients (median: 41 mo, mean: 54 mo) showed 10 patients were alive without disease, 5 were alive with disease, 1 died of other cause, and 1 died of disease. Local recurrence developed in 9 cases and metastasis in 2 cases, although neither correlated with grade as defined. On the basis of clinical follow-up to date, the natural history of lymphatic-type angiosarcoma appears to be more favorable than other forms of cutaneous angiosarcoma.
Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma

Science Translational Medicine | September 1, 2011 | Volume: 3 | Issue: 98 | Pages: No page available

10.1126/scitranslmed.3002409 | PMID 21885404

A newly identified gene fusion defines the vascular cancer epithelioid hemangioendothelioma and encodes a chimeric transcription factor.